SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Equities researchers at Raymond James lowered their Q1 2025 earnings estimates for shares of SNC-Lavalin Group in a report issued on Friday, March 14th. Raymond James analyst F. Bastien now anticipates that the company will post earnings of $0.54 per share for the quarter, down from their previous forecast of $0.57. Raymond James also issued estimates for SNC-Lavalin Group’s Q2 2025 earnings at $0.65 EPS, Q4 2025 earnings at $0.82 EPS, Q1 2026 earnings at $0.70 EPS, Q2 2026 earnings at $0.84 EPS, Q3 2026 earnings at $1.01 EPS and Q4 2026 earnings at $0.85 EPS.
Separately, Stifel Canada upgraded shares of SNC-Lavalin Group to a “strong-buy” rating in a research report on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Recommended Stories
- Five stocks we like better than SNC-Lavalin Group
- Why Invest in 5G? How to Invest in 5G Stocks
- How to Build the Ultimate Everything ETF Portfolio
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What Are the FAANG Stocks and Are They Good Investments?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
